At 5.9% CAGR, the Europe Wound Dressing Market is projected to be worth US$ 4,380.67 million by 2028, says Business Market Insights      

According to Business Market Insights’ research, the Europe wound dressing market was valued at US$ 3,105.95 million in 2022 and is expected to reach US$ 4,380.67 million by 2028, registering an annual growth rate of 5.9%  from 2022 to 2028. Rising prevalence of chronic diseases & related wounds and increasing number of traumatic injuries are the critical factors attributed to the market expansion.       

An increase in chronic diseases, such as diabetes, cancer, and other autoimmune disorders is burdening the healthcare system across the region. Chronic diseases directly impact the body's natural ability to heal. Diabetes and immunodeficiency conditions are among the most detrimental conditions that can slow wound repair. Diabetes is the chronic disease most identified and associated as a risk factor for hospital-acquired and facility pressure injuries. Diabetes impacts the immune system, making infections more common and complicating wound healing. It is one of the most significant global health emergencies of the 21st century. The prolonged healing process due to chronic diseases leads to a long-term need for wound dressings, resulting in high demand for them. Moreover, the increased prevalence of cancer has fueled the number of interventions performed. As a result, wound dressings are used more often to prevent postoperative wound infections. Most surgical wounds after cancer surgery are large and deep, resulting in exudate that requires frequent management. Advanced wound dressings, such as hydrogels, alginates, and foams, help with wound management and infection prevention. As a result, the rise in the incidence of chronic diseases is adding to the demand for wound care products, driving the market.

On the contrary, unfavorable reimbursement scenario hurdles the growth of Europe wound dressing market.    

• Based on wound dressing type, the Europe wound dressing market is bifurcated into advanced wound dressing and traditional wound dressing. The advanced wound dressing segment held 67.5% market share in 2022, amassing US$ 2,095.67 million. It is projected to garner US$ 3,004.49 million by 2028 to expand at 6.2% CAGR during 2022–2028. The advanced wound dressing is further segmented into foam dressings, superabsorbent dressings, film dressings, hydrocolloids dressings, wound contact layers, collagen dressings, and others. The traditional wound dressing is also segmented into dry dressings, surgical tapes, and anti-infective dressings.  
• Based on application, the Europe wound dressing market is bifurcated into chronic wound and acute wound. The chronic wound segment held 61.2% market share in 2022, amassing US$ 1,900.24 million. It is projected to garner US$ 2,725.51 million by 2028 to expand at 6.2% CAGR during 2022–2028. The chronic wound segment is further segmented into pressure ulcers, diabetic foot ulcers, venous leg ulcers, and other chronic wounds. Similarly, the acute wound segment is bifurcated into surgical and traumatic wounds and burns wounds.  
• Based on end user, the Europe wound dressing market is segmented into hospitals, ambulatory surgical centers, clinics, and others. The hospitals segment held 40.2% market share in 2022, amassing US$ 1,250.07 million. It is projected to garner US$ 1,833.09 million by 2028 to expand at 6.6% CAGR during 2022–2028.       
• Based on country, the Europe wound dressing market has been categorized into the UK, Germany, France, Italy, Spain, and rest of Europe. Our regional analysis states that Germany captured 29.9% market share in 2022. It was assessed at US$ 927.13 million in 2022 and is likely to hit US$ 1,366.77 million by 2028, exhibiting a CAGR of 6.7% during the forecast period.        

Key players dominating the Europe wound dressing market are 3M; Advancis Medical; Axio Biosolutions Pvt Ltd; Coloplast Corp; Convatec Inc.; Integra LifeSciences Holdings Corporation; Medline Industries, Inc.; Medtronic; Mölnlycke Health Care AB.; and Smith+Nephew among others.

In June 2022, Medline announced the launch of its Optifoam Gentle EX Foam Dressing. The product is designed to help displace pressure when used with pressure injury prevention protocol. The product features five unique layers to help absorb shear force and friction and manage moisture.

• In July 2021, Integra LifeSciences Announced Positive Clinical Outcomes for PriMatrix Dermal Repair Scaffold For The Management Of Diabetic Foot Ulcers.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com